Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 77.90
+0.40 (0.52%)
At close: Sep 30, 2025
Nextage Therapeutics Company Description
Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel.
Nextage Therapeutics Ltd
| Country | Israel |
| Founded | 1982 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Orna Dreazen |
Contact Details
Address: Einstein Street Building 13B Ness Ziona, 7403617 Israel | |
| Phone | 972 7 3224 4440 |
| Website | nxtg.co.il |
Stock Details
| Ticker Symbol | NXTG |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0004330119 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Orna Dreazen Ph.D. | Chief Executive Officer |
| Abraham Dreazen | Vice President Strategy and BD |
| Guy Chavia | Chief Financial Officer |
| Avi Semel | Vice President of Operations |
| Jacob Mix | Internal Legal Counsel |
| Daniel Shapira | Internal Auditor |